High Times
Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/31/2018 5:57:22 PM - Followers: 4 - Board type: Free - Posts Today: 0

Aclaris Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 United States 484-324-7933 http://www.aclaristx.com Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
High Times
ACRS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS News: Current Report Filing (8-k) 10/15/2018 04:20:58 PM
ACRS News: Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADEĀ® from Allergan 10/15/2018 04:01:00 PM
ACRS News: Statement of Changes in Beneficial Ownership (4) 10/05/2018 04:46:30 PM
ACRS News: Current Report Filing (8-k) 10/04/2018 05:02:00 PM
ACRS News: Aclaris Therapeutics Announces Poster Presentations at 2018 American Society for Dermatologic Surgery Annual Meeting and Fall... 10/03/2018 07:00:00 AM
News News Alert: Current Report Filing (8-k) 10/15/2018 04:20:58 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3   This stock going to $30 after FDA approval! Engle1488 07/31/18 05:57:22 PM
#2   You proved right about this stock since your HappyLibrarian 01/24/18 09:52:56 AM
#1   ACRS bullish 22.07 stocktrademan 09/06/16 11:44:47 AM
PostSubject